{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:46:36Z","timestamp":1790811996061,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12928-022-00907-6","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T06:04:01Z","timestamp":1673071441000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Complete revascularization in acute myocardial infarction: a clinical review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-0685","authenticated-orcid":false,"given":"Yuichi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"key":"907_CR1","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","volume":"136","author":"E Puymirat","year":"2017","unstructured":"Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation. 2017;136:1908\u201319.","journal-title":"Circulation"},{"key":"907_CR2","first-page":"117","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2013","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2013;385:117\u201371.","journal-title":"Lancet"},{"key":"907_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12928-021-00829-9","volume":"37","author":"Y Ozaki","year":"2022","unstructured":"Ozaki Y, Hara H, Onuma Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Cardiovasc Interv Ther. 2022;37:1\u201334.","journal-title":"Cardiovasc Interv Ther"},{"key":"907_CR4","doi-asserted-by":"publisher","first-page":"e006363","DOI":"10.1161\/CIRCOUTCOMES.119.006363","volume":"13","author":"L Chacko","year":"2020","unstructured":"Chacko L, Howard PJ, Rajkumar C, et al. Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2020;13:e006363.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"907_CR5","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIRCULATIONAHA.121.057538","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022;145:e18-114.","journal-title":"Circulation"},{"key":"907_CR6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.jacc.2018.07.089","volume":"72","author":"KS Rathod","year":"2018","unstructured":"Rathod KS, Koganti S, Jain AK, et al. Complete versus culprit-only lesion intervention in patients with acute coronary syndromes. J Am Coll Cardiol. 2018;72:1989\u201399.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR7","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2014.15095","volume":"312","author":"DW Park","year":"2014","unstructured":"Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312:2019\u201327.","journal-title":"JAMA"},{"key":"907_CR8","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","volume":"28","author":"P Sorajja","year":"2007","unstructured":"Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28:1709\u201316.","journal-title":"Eur Heart J"},{"key":"907_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jacc.2016.05.086","volume":"68","author":"ER Bates","year":"2016","unstructured":"Bates ER, Tamis-Holland JE, Bittl JA, et al. PCI strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. J Am Coll Cardiol. 2016;68:1066\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-020-00457-5","volume":"18","author":"P Gaba","year":"2021","unstructured":"Gaba P, Gersh BJ, Ali ZA, et al. Complete versus incomplete coronary revascularization: definitions, assessment and outcomes. Nat Rev Cardiol. 2021;18:155\u201368.","journal-title":"Nat Rev Cardiol"},{"key":"907_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jjcc.2019.04.001","volume":"74","author":"Y Saito","year":"2019","unstructured":"Saito Y, Kobayashi Y. Percutaneous coronary intervention strategies in patients with acute myocardial infarction and multivessel disease: completeness, timing, lesion assessment, and patient status. J Cardiol. 2019;74:95\u2013101.","journal-title":"J Cardiol"},{"key":"907_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","volume":"369","author":"DS Wald","year":"2013","unstructured":"Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115\u201323.","journal-title":"N Engl J Med"},{"key":"907_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","volume":"65","author":"AH Gershlick","year":"2015","unstructured":"Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","volume":"386","author":"T Engstr\u00f8m","year":"2015","unstructured":"Engstr\u00f8m T, Kelb\u00e6k H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3\u2014PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665\u201371.","journal-title":"Lancet"},{"key":"907_CR15","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","volume":"376","author":"PC Smits","year":"2017","unstructured":"Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234\u201344.","journal-title":"N Engl J Med"},{"key":"907_CR16","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","volume":"381","author":"SR Mehta","year":"2019","unstructured":"Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2019;381:1411\u201321.","journal-title":"N Engl J Med"},{"key":"907_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008768","volume":"13","author":"N Pinilla-Echeverri","year":"2020","unstructured":"Pinilla-Echeverri N, Mehta SR, Wang J, et al. Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction: results from the COMPLETE trial optical coherence tomography substudys. Circ Cardiovasc Interv. 2020;13: e008768.","journal-title":"Circ Cardiovasc Interv"},{"key":"907_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.amjcard.2020.08.030","volume":"135","author":"JY Levett","year":"2020","unstructured":"Levett JY, Windle SB, Filion KB, et al. Meta-analysis of complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Am J Cardiol. 2020;135:40\u20139.","journal-title":"Am J Cardiol"},{"key":"907_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015263","volume":"9","author":"Y Ahmad","year":"2020","unstructured":"Ahmad Y, Howard JP, Arnold A, et al. Complete revascularization by percutaneous coronary intervention for patients with ST-segment-elevation myocardial infarction and multivessel coronary artery disease: an updated meta-analysis of randomized trials. J Am Heart Assoc. 2020;9: e015263.","journal-title":"J Am Heart Assoc"},{"key":"907_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamacardio.2020.1251","volume":"5","author":"KR Bainey","year":"2020","unstructured":"Bainey KR, Engstrom T, Smits PC, et al. Complete vs culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. JAMA Cardiol. 2020;5:881\u20138.","journal-title":"JAMA Cardiol"},{"key":"907_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jamacardio.2022.3032","volume":"7","author":"SR Mehta","year":"2022","unstructured":"Mehta SR, Wang J, Wood DA, et al. Complete revascularization vs culprit lesion-only percutaneous coronary intervention for angina-related quality of life in patients with ST-segment elevation myocardial infarction: results from the COMPLETE randomized clinical trial. JAMA Cardiol. 2022;7:1091\u20139.","journal-title":"JAMA Cardiol"},{"key":"907_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa2201546","volume":"387","author":"BK Koo","year":"2022","unstructured":"Koo BK, Hu X, Kang J, et al. Fractional flow reserve or intravascular ultrasonography to guide PCI. N Engl J Med. 2022;387:779\u201389.","journal-title":"N Engl J Med"},{"key":"907_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ehjqcco\/qcaa012","volume":"6","author":"DS Wald","year":"2020","unstructured":"Wald DS, Hadyanto S, Bestwick JP. Should fractional flow reserve follow angiographic visual inspection to guide preventive percutaneous coronary intervention in ST-elevation myocardial infarction? Eur Heart J Qual Care Clin Outcomes. 2020;6:186\u201392.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"907_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jcin.2010.08.025","volume":"3","author":"A Ntalianis","year":"2010","unstructured":"Ntalianis A, Sels JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274\u201381.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jcin.2016.01.001","volume":"9","author":"GA de Waard","year":"2016","unstructured":"de Waard GA, Hollander MR, Teunissen PF, et al. Changes in coronary blood flow after acute myocardial infarction: insights from a patient study and an experimental porcine model. JACC Cardiovasc Interv. 2016;9:602\u201313.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jamacardio.2019.2138","volume":"4","author":"NW van der Hoeven","year":"2019","unstructured":"van der Hoeven NW, Janssens GN, de Waard GA, et al. Temporal changes in coronary hyperemic and resting hemodynamic indices in nonculprit vessels of patients With ST-segment elevation myocardial infarction. JAMA Cardiol. 2019;4:736\u201344.","journal-title":"JAMA Cardiol"},{"key":"907_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJMoa2104650","volume":"385","author":"E Puymirat","year":"2021","unstructured":"Puymirat E, Cayla G, Simon T, et al. Multivessel PCI guided by FFR or angiography for myocardial infarction. N Engl J Med. 2021;385:297\u2013308.","journal-title":"N Engl J Med"},{"key":"907_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ccd.30304","volume":"100","author":"Y Okuya","year":"2022","unstructured":"Okuya Y, Gohil K, Moussa ID. Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: network meta-analysis. Catheter Cardiovasc Interv. 2022;100:340\u201350.","journal-title":"Catheter Cardiovasc Interv"},{"key":"907_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jcin.2022.01.002","volume":"15","author":"A Elbadawi","year":"2022","unstructured":"Elbadawi A, Dang AT, Hamed M, et al. FFR-versus angiography-guided revascularization for nonculprit stenosis in STEMI and multivessel disease: a network meta-analysis. JACC Cardiovasc Interv. 2022;15:656\u201366.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR30","doi-asserted-by":"publisher","unstructured":"Lee JM, Kim HK, Park KH, et al. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. Eur Heart J. 2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehac763.","DOI":"10.1093\/eurheartj\/ehac763"},{"key":"907_CR31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jacc.2020.07.034","volume":"76","author":"T Sheth","year":"2020","unstructured":"Sheth T, Pinilla-Echeverri N, Moreno R, et al. Nonculprit lesion severity and outcome of revascularization in patients with STEMI and multivessel coronary disease. J Am Coll Cardiol. 2020;76:1277\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119\u201377.","journal-title":"Eur Heart J"},{"key":"907_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12928-022-00863-1","volume":"37","author":"Y Kawase","year":"2022","unstructured":"Kawase Y, Matsuo H, Kuramitsu S, et al. Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention and therapeutics-update 2022. Cardiovasc Interv Ther. 2022;37:425\u201339.","journal-title":"Cardiovasc Interv Ther"},{"key":"907_CR34","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1016\/j.jcin.2017.07.021","volume":"10","author":"T Thim","year":"2017","unstructured":"Thim T, Gotberg M, Frobert O, et al. Nonculprit stenosis evaluation using instantaneous wave-free ratio in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2017;10:2528\u201335.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044035","volume":"11","author":"CWH Beijnink","year":"2021","unstructured":"Beijnink CWH, Thim T, van der Heijden DJ, et al. Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: study protocol of the randomised controlled iMODERN trial. BMJ Open. 2021;11: e044035.","journal-title":"BMJ Open"},{"key":"907_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ahj.2013.07.027","volume":"166","author":"A Bagai","year":"2013","unstructured":"Bagai A, Thavendiranathan P, Sharieff W, et al. Non-infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J. 2013;166:684\u201393.","journal-title":"Am Heart J"},{"key":"907_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jcin.2018.02.028","volume":"11","author":"V Pasceri","year":"2018","unstructured":"Pasceri V, Patti G, Pelliccia F, et al. Complete revascularization during primary percutaneous coronary intervention reduces death and myocardial infarction in patients with multivessel disease: meta-analysis and meta-regression of randomized trials. JACC Cardiovasc Interv. 2018;11:833\u201343.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jacc.2015.10.082","volume":"67","author":"G Sardella","year":"2016","unstructured":"Sardella G, Lucisano L, Garbo R, et al. Single-staged compared with multi-staged PCI in multivessel NSTEMI Patients: the SMILE trial. J Am Coll Cardiol. 2016;67:264\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005381","volume":"6","author":"R Gaffar","year":"2017","unstructured":"Gaffar R, Habib B, Filion KB, et al. Optimal timing of complete revascularization in acute coronary syndrome: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6: e005381.","journal-title":"J Am Heart Assoc"},{"key":"907_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.695822","volume":"8","author":"K Cui","year":"2021","unstructured":"Cui K, Yin D, Zhu C, et al. Optimal revascularization strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis. Front Cardiovasc Med. 2021;8: 695822.","journal-title":"Front Cardiovasc Med"},{"key":"907_CR41","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.jacc.2019.09.051","volume":"74","author":"DA Wood","year":"2019","unstructured":"Wood DA, Cairns JA, Wang J, et al. Timing of staged nonculprit artery revascularization in patients with ST-segment elevation myocardial infarction: COMPLETE trial. J Am Coll Cardiol. 2019;74:2713\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87\u2013165.","journal-title":"Eur Heart J"},{"key":"907_CR43","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1093\/eurheartj\/ehac213","volume":"43","author":"TA Kite","year":"2022","unstructured":"Kite TA, Kurmani SA, Bountziouka V, et al. Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials. Eur Heart J. 2022;43:3148\u201361.","journal-title":"Eur Heart J"},{"key":"907_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006343","volume":"6","author":"H Ibrahim","year":"2017","unstructured":"Ibrahim H, Sharma PK, Cohen DJ, et al. Multivessel versus culprit vessel-only percutaneous coronary intervention among patients with acute myocardial infarction: insights from the TRANSLATE-ACS observational study. J Am Heart Assoc. 2017;6: e006343.","journal-title":"J Am Heart Assoc"},{"key":"907_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016575","volume":"9","author":"MC Kim","year":"2020","unstructured":"Kim MC, Hyun JY, Ahn Y, et al. Optimal revascularization strategy in non-ST-segment-elevation myocardial infarction with multivessel coronary artery disease: culprit-only versus one-stage versus multistage revascularization. J Am Heart Assoc. 2020;9: e016575.","journal-title":"J Am Heart Assoc"},{"key":"907_CR46","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jcin.2020.04.034","volume":"13","author":"KR Bainey","year":"2020","unstructured":"Bainey KR, Alemayehu W, Armstrong PW, et al. Long-term outcomes of complete revascularization with percutaneous coronary intervention in acute coronary syndromes. JACC Cardiovasc Interv. 2020;13:1557\u201367.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR47","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jcin.2010.06.017","volume":"3","author":"Y Ben-Gal","year":"2010","unstructured":"Ben-Gal Y, Moses JW, Mehran R, et al. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC Cardiovasc Interv. 2010;3:1059\u201367.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjcard.2017.04.038","volume":"120","author":"M Chang","year":"2017","unstructured":"Chang M, Lee CW, Ahn JM, et al. Comparison of outcome of coronary artery bypass grafting versus drug-eluting stent implantation for non-ST-elevation acute coronary syndrome. Am J Cardiol. 2017;120:380\u20136.","journal-title":"Am J Cardiol"},{"key":"907_CR49","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","volume":"391","author":"SJ Head","year":"2018","unstructured":"Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391:939\u201348.","journal-title":"Lancet"},{"key":"907_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289\u2013367.","journal-title":"Eur Heart J"},{"key":"907_CR51","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ahj.2012.03.003","volume":"163","author":"HH Awad","year":"2012","unstructured":"Awad HH, Anderson FA Jr, Gore JM, et al. Cardiogenic shock complicating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2012;163:963\u201371.","journal-title":"Am Heart J"},{"key":"907_CR52","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000590","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3: e000590.","journal-title":"J Am Heart Assoc"},{"key":"907_CR53","first-page":"1672","volume":"12","author":"T Sato","year":"2022","unstructured":"Sato T, Saito Y, Suzuki S, et al. Prognostic factors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock. Life (Basel). 2022;12:1672.","journal-title":"Life (Basel)"},{"key":"907_CR54","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"907_CR55","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","volume":"295","author":"JS Hochman","year":"2006","unstructured":"Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511\u20135.","journal-title":"JAMA"},{"key":"907_CR56","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcin.2021.02.021","volume":"14","author":"MA Omer","year":"2021","unstructured":"Omer MA, Brilakis ES, Kennedy KF, et al. Multivessel versus culprit-vessel percutaneous coronary intervention in patients with non-ST-segment elevation myocardial infarction and cardiogenic shock. JACC Cardiovasc Interv. 2021;14:1067\u201378.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR57","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamainternmed.2020.3276","volume":"180","author":"R Khera","year":"2020","unstructured":"Khera R, Secemsky EA, Wang Y, et al. Revascularization practices and outcomes in patients with multivessel coronary artery disease who presented with acute myocardial infarction and cardiogenic shock in the US, 2009\u20132018. JAMA Intern Med. 2020;180:1317\u201327.","journal-title":"JAMA Intern Med"},{"key":"907_CR58","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jacc.2017.12.028","volume":"71","author":"JM Lee","year":"2018","unstructured":"Lee JM, Rhee TM, Hahn JY, et al. Multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction with cardiogenic shock. J Am Coll Cardiol. 2018;71:844\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR59","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","volume":"379","author":"H Thiele","year":"2018","unstructured":"Thiele H, Akin I, Sandri M, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699\u2013710.","journal-title":"N Engl J Med"},{"key":"907_CR60","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H Thiele","year":"2017","unstructured":"Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377:2419\u201332.","journal-title":"N Engl J Med"},{"key":"907_CR61","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/CIRCULATIONAHA.117.032907","volume":"137","author":"H Thiele","year":"2018","unstructured":"Thiele H, Desch S. CULPRIT-SHOCK (culprit lesion only PCI versus multivessel percutaneous coronary intervention in cardiogenic shock): implications on guideline recommendations. Circulation. 2018;137:1314\u20136.","journal-title":"Circulation"},{"key":"907_CR62","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jcin.2020.04.003","volume":"13","author":"P Guedeney","year":"2020","unstructured":"Guedeney P, Barthelemy O, Zeitouni M, et al. Prognostic value of SYNTAX score in patients with infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK trial. JACC Cardiovasc Interv. 2020;13:1198\u2013206.","journal-title":"JACC Cardiovasc Interv"},{"key":"907_CR63","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"VP Harjola","year":"2015","unstructured":"Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17:501\u20139.","journal-title":"Eur J Heart Fail"},{"key":"907_CR64","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(20)32338-2","volume":"396","author":"D Yannopoulos","year":"2020","unstructured":"Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396:1807\u201316.","journal-title":"Lancet"},{"key":"907_CR65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062949","author":"P Ostadal","year":"2022","unstructured":"Ostadal P, Rokyta R, Karasek J, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2022. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062949.","journal-title":"Circulation"},{"key":"907_CR66","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","volume":"139","author":"H Thiele","year":"2019","unstructured":"Thiele H, Zeymer U, Thelemann N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation. 2019;139:395\u2013403.","journal-title":"Circulation"},{"key":"907_CR67","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287\u201396.","journal-title":"N Engl J Med"},{"key":"907_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.856870","volume":"9","author":"A Attinger-Toller","year":"2022","unstructured":"Attinger-Toller A, Bossard M, Cioffi GM, et al. Ventricular unloading using the impella(TM) device in cardiogenic shock. Front Cardiovasc Med. 2022;9: 856870.","journal-title":"Front Cardiovasc Med"},{"key":"907_CR69","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011778","volume":"15","author":"TA Bjarnason","year":"2022","unstructured":"Bjarnason TA, Mentias A, Panaich S, et al. Diffusion of percutaneous ventricular assist devices in US markets. Circ Cardiovasc Interv. 2022;15: e011778.","journal-title":"Circ Cardiovasc Interv"},{"key":"907_CR70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","volume":"141","author":"AP Amin","year":"2020","unstructured":"Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020;141:273\u201384.","journal-title":"Circulation"},{"key":"907_CR71","doi-asserted-by":"publisher","first-page":"e1343","DOI":"10.4244\/EIJ-D-19-00428","volume":"15","author":"A Chieffo","year":"2020","unstructured":"Chieffo A, Ancona MB, Burzotta F, et al. Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry. EuroIntervention. 2020;15:e1343\u201350.","journal-title":"EuroIntervention"},{"key":"907_CR72","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37748","volume":"4","author":"SS Dhruva","year":"2021","unstructured":"Dhruva SS, Ross JS, Mortazavi BJ, et al. Use of mechanical circulatory support devices among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA Netw Open. 2021;4: e2037748.","journal-title":"JAMA Netw Open"},{"key":"907_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2018.03.024","volume":"202","author":"WW O'Neill","year":"2018","unstructured":"O\u2019Neill WW, Grines C, Schreiber T, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. 2018;202:33\u20138.","journal-title":"Am Heart J"},{"key":"907_CR74","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.120.048792","volume":"142","author":"B Schrage","year":"2020","unstructured":"Schrage B, Becher PM, Bernhardt A, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study. Circulation. 2020;142:2095\u2013106.","journal-title":"Circulation"},{"key":"907_CR75","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/2048872618757393","volume":"9","author":"JT Sieweke","year":"2020","unstructured":"Sieweke JT, Berliner D, Tongers J, et al. Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure. Eur Heart J Acute Cardiovasc Care. 2020;9:138\u201348.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"907_CR76","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","volume":"139","author":"B Schrage","year":"2019","unstructured":"Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019;139:1249\u201358.","journal-title":"Circulation"},{"key":"907_CR77","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jama.2020.0254","volume":"323","author":"SS Dhruva","year":"2020","unstructured":"Dhruva SS, Ross JS, Mortazavi BJ, et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2020;323:734\u201345.","journal-title":"JAMA"},{"key":"907_CR78","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","volume":"69","author":"DM Ouweneel","year":"2017","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:278\u201387.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR79","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/ehjacc\/zuab060","volume":"10","author":"M Karami","year":"2021","unstructured":"Karami M, Eriksen E, Ouweneel DM, et al. Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021;10:1009\u201315.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"907_CR80","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2022.01.032","volume":"79","author":"EW Grandin","year":"2022","unstructured":"Grandin EW, Nunez JI, Willar B, et al. Mechanical left ventricular unloading in patients undergoing venoarterial extracorporeal membrane oxygenation. J Am Coll Cardiol. 2022;79:1239\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"907_CR81","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.jacc.2022.08.807","volume":"80","author":"M Pahuja","year":"2022","unstructured":"Pahuja M, Johnson A, Kabir R, et al. Randomized trials of percutaneous microaxial flow pump devices. J Am Coll Cardiol. 2022;80:2028\u201349.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-022-00907-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-022-00907-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-022-00907-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:32:02Z","timestamp":1744209122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-022-00907-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s12928-022-00907-6","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yuichi Saito declares no conflicts of interest to disclose. Yoshio Kobayashi is a recipient of research grants from Abbott, Boston Scientific, Medtronic, Nipro, and Terumo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}